very hot tip, page-5

My call is that...

~ the trial will be a success, as all previous data suggests it will be.

~ then Novozymes will take over tis. They are already in each others work space.

It should be at a good price too. The sp is much lower than it has been, but this is on very low volume and because of tis's low amount of funds. All the big holders are still holding.

I would expect a takeover to be at least 80c to be successful. Maybe more, given tis's low mkt cap & the value of their product.

Just my opinion.